Orthopedic Roundup Q4: S&N, Stryker, J&J, Zimmer Biomet See Pandemic-Related Sales Impact
Executive Summary
The resurgence of the pandemic during the fourth quarter of 2020 led to slowdown in elective procedures, negatively impacting sales of the four big ortho players.
You may also be interested in...
AAOS 2022 Roundup: Stryker, Zimmer Biomet, J&J’s DePuy Synthes, Canary Medical
In this first of two roundups, Medtech Insight highlights new product launches and technologies showcased at the annual AAOS conference by three major orthopedics players and medical data company Canary Medical.
Hospital Staffing Shortages Could Impede Recovery Of Procedure Volumes
Even as COVID-19 hospitalization rates are declining, expected staff shortages could force more hospitals to postpone surgeries and interventions in the coming months.
Zimmer Biomet Receives FDA Nod For Rosa Total Hip System, Intensifying Ortho Robotics Rivalry
Zimmer Biomet adds total hip replacement to its Rosa robotic platform, which will compete against Stryker’s Mako.